Cargando…
Chronic Ingestion of Flavan-3-ols and Isoflavones Improves Insulin Sensitivity and Lipoprotein Status and Attenuates Estimated 10-Year CVD Risk in Medicated Postmenopausal Women With Type 2 Diabetes: A 1-year, double-blind, randomized, controlled trial
OBJECTIVE: To assess the effect of dietary flavonoids on cardiovascular disease (CVD) risk in postmenopausal women with type 2 diabetes on established statin and hypoglycemic therapy. RESEARCH DESIGN AND METHODS: Despite being medicated, patients with type 2 diabetes have elevated CVD risk, particul...
Autores principales: | Curtis, Peter J., Sampson, Mike, Potter, John, Dhatariya, Ketan, Kroon, Paul A., Cassidy, Aedín |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3263874/ https://www.ncbi.nlm.nih.gov/pubmed/22250063 http://dx.doi.org/10.2337/dc11-1443 |
Ejemplares similares
-
Analysis of Conformational, Structural, Magnetic,
and Electronic Properties Related to Antioxidant Activity: Revisiting
Flavan, Anthocyanidin, Flavanone, Flavonol, Isoflavone, Flavone, and
Flavan-3-ol
por: de Souza Farias, Sergio Antônio, et al.
Publicado: (2021) -
Dietary intakes of flavan-3-ols and cardiometabolic health: systematic review and meta-analysis of randomized trials and prospective cohort studies
por: Raman, Gowri, et al.
Publicado: (2019) -
Dietary intakes of flavan-3-ols and cardiovascular health: a field synopsis using evidence mapping of randomized trials and prospective cohort studies
por: Raman, Gowri, et al.
Publicado: (2018) -
Associations between flavan-3-ol intake and CVD risk in the Norfolk cohort of the European Prospective Investigation into Cancer (EPIC-Norfolk)
por: Vogiatzoglou, Anna, et al.
Publicado: (2015) -
Enantioselctive Syntheses of Sulfur Analogues of Flavan-3-Ols
por: Sharma, Pradeep K., et al.
Publicado: (2010)